Newly revised measures released by the State Administration for Market Regulation for the supervision and administration of medical device production and operation will take effect on 1 May. A system of registration and record-filing in relation to medical devices will help to optimise administrative licensing procedures and supervision.

The Good Agricultural Practice (GAP) for Chinese Crude Drugs, jointly released by the National Medical Products Administration and other central departments, took effect on 1 March. The GAP will apply to the management of the whole process of herbal drug cultivation and will be used as a reference guide in the collection and processing of wild medicinal materials by the industry.

Hong Kong has the highest life expectancy in the world thanks to its advanced healthcare services. In addition, the city expects to be home to an increasingly aging population, as is the case with many other developed economies, in the years to come. The number of elderly people aged 65 or above is projected to increase from 20% of the total population in 2021 to 32% by 2041.

In its notice on the work of medical device adverse event monitoring in 2022, the Medical Products Administration of Guangdong said registration and record-filing parties must carry out adverse event monitoring and implement quality management systems in medical device production.